EV00.MU - Evoke Pharma Inc

Munich - Munich Delayed price. Currency in EUR
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,509
2,509
1,618
23.02
0
Cost of revenue
370.394
370.394
328.118
86.712
-
Gross profit
2,138
2,138
1,290
-63.692
-
Operating expenses
Research development
300.789
300.789
590.476
6,555
3,416
Selling general and administrative
9,624
9,624
8,851
6,429
3,738
Total operating expenses
9,924
9,924
9,442
12,984
7,154
Operating income or loss
-7,786
-7,786
-8,152
-13,047
-7,154
Interest expense
500
500
500.05
112.994
-
Total other income/expenses net
-
-
105.13
-
-
Income before tax
-8,224
-8,224
-8,538
-13,155
-7,126
Income from continuing operations
-8,224
-8,224
-8,538
-13,155
-7,126
Net income
-8,224
-8,224
-8,538
-13,155
-7,126
Net income available to common shareholders
-8,224
-8,224
-8,538
-13,155
-7,126
Basic EPS
-
-2.62
-3.18
-6.24
-3.84
Diluted EPS
-
-2.62
-3.18
-6.24
-3.84
Basic average shares
-
3,144
2,682
2,124
1,858
Diluted average shares
-
3,144
2,682
2,124
1,858
EBITDA
-
-7,724
-8,038
-13,042
-7,154